Invesco Biotechnology & Genome ETF
PBE
PBE
74 hedge funds and large institutions have $53.2M invested in Invesco Biotechnology & Genome ETF in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
41% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 22
Holders
74
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$639K | |
| 2 | +$377K | |
| 3 | +$302K | |
| 4 |
Morgan Stanley
New York
|
+$298K |
| 5 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$205K |
Top Sellers
| 1 | -$1.47M | |
| 2 | -$333K | |
| 3 | -$320K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$228K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$225K |